Radiopharm Theranostics Ltd has released a press release.
Security Class Suspension from Quotation RADO
Filed with ASX ·
6ix hasn’t read this filing yet.
Radiopharm Theranostics Limited on 6ix
Earlier from Radiopharm Theranostics
- Entitlement Offer - Extension of Retail Offer
- RAD agreement with NorthStar for supply of Actinium-225
- Successful Completion of Institutional Entitlement Offer
- Entitlement Offer to raise up to $10 million
- Pivalate achieves positive Phase 2 data in brain mets trial
Later from Radiopharm Theranostics
- Security Class Reinstatement to Quotation
- aVb6 Integrin (RAD301) IND approval for Phase 1 trial
- Radiopharm Theranostics initiates process for Nasdaq listing
- Appendix 4D and Half Year Report
- Radiopharm to acquire Pharma15 Corporation
Follow Radiopharm Theranostics into a list and get an email when it puts out news.
Follow Radiopharm Theranostics